Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-27

Clinical Trial Update: A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant [Phase 3]

View source ↗

Summary

Phase 3 study of Seltorexant as adjunctive therapy to antidepressants for adults and elderly with major depressive disorder with insomnia symptoms; the trial st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Seltorexant (seltorexant)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Depressive Disorder, Major | Phase 3 | Status: COMPLETED